Wells Fargo’s Century Therapeutics IPSC Stock Holding History

Wells Fargo’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$90	Hold	40	–	–	﹤0.01%	6514
2025 Q4	$40	Buy	+40	New	+$24	﹤0.01%	6570
2025 Q3	–	Sell	-861	Closed	-$481	–	7239
2025 Q2	$481	Sell	861 -27,977	-97%	-$15K	﹤0.01%	6376
2025 Q1	$13.7K	Buy	28,838 +622	+2%	+$467	﹤0.01%	5815
2024 Q4	$28.5K	Buy	28,216 +5,981	+27%	+$8.14K	﹤0.01%	5668
2024 Q3	$38K	Buy	22,235 +2,077	+10%	+$4.07K	﹤0.01%	5445
2024 Q2	$51.4K	Buy	20,158 +11,895	+144%	+$37.6K	﹤0.01%	5282
2024 Q1	$34.5K	Buy	8,263 +1,060	+15%	+$4.49K	﹤0.01%	5395
2023 Q4	$23.9K	Buy	7,203 +1,422	+25%	+$2.59K	﹤0.01%	5573
2023 Q3	$11.6K	Sell	5,781 -3,124	-35%	-$8.31K	﹤0.01%	5765
2023 Q2	$28.1K	Buy	8,905 +5,321	+148%	+$17.2K	﹤0.01%	5633
2023 Q1	$12.4K	Buy	+3,584	New	+$15.7K	﹤0.01%	5788
2022 Q4	–	Sell	-57	Closed	-$1K	–	7586
2022 Q3	$1K	Sell	57 -138	-71%	-$1.45K	﹤0.01%	6368
2022 Q2	$2K	Sell	195 -13,713	-99%	-$135K	﹤0.01%	6332
2022 Q1	$175K	Sell	13,908 -943	-6%	-$12.5K	﹤0.01%	5053
2021 Q4	$235K	Buy	14,851 +14,793	+25,505%	+$278K	﹤0.01%	5180
2021 Q3	$1K	Buy	+58	New	+$1.57K	﹤0.01%	6723

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wells Fargo's IPSC Position: Q1 2026 in Review

Wells Fargo held its Century Therapeutics (IPSC) position steady in Q1 2026 at 40 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #6514.

Wells Fargo first reported a position in IPSC in Q3 2021 and has held it in 17 quarters since. The position peaked at $235K in Q4 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Wells Fargo held 40 shares of Century Therapeutics worth $90 as of Q1 2026.
Wells Fargo left its Century Therapeutics share count unchanged in Q1 2026.
Century Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6514 holding.
Wells Fargo first reported a position in Century Therapeutics in Q3 2021 and has held it in 17 quarters since.
Wells Fargo's Century Therapeutics position peaked at $235K in Q4 2021.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.